"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 22 | 14 | 36 |
| 1997 | 25 | 14 | 39 |
| 1998 | 36 | 12 | 48 |
| 1999 | 27 | 17 | 44 |
| 2000 | 14 | 12 | 26 |
| 2001 | 19 | 13 | 32 |
| 2002 | 8 | 5 | 13 |
| 2003 | 18 | 8 | 26 |
| 2004 | 13 | 15 | 28 |
| 2005 | 14 | 10 | 24 |
| 2006 | 18 | 12 | 30 |
| 2007 | 9 | 10 | 19 |
| 2008 | 8 | 12 | 20 |
| 2009 | 12 | 9 | 21 |
| 2010 | 13 | 13 | 26 |
| 2011 | 13 | 8 | 21 |
| 2012 | 13 | 11 | 24 |
| 2013 | 17 | 14 | 31 |
| 2014 | 19 | 11 | 30 |
| 2015 | 4 | 13 | 17 |
| 2016 | 13 | 9 | 22 |
| 2017 | 11 | 6 | 17 |
| 2018 | 8 | 8 | 16 |
| 2019 | 8 | 13 | 21 |
| 2020 | 8 | 10 | 18 |
| 2021 | 7 | 6 | 13 |
| 2022 | 1 | 7 | 8 |
| 2023 | 0 | 9 | 9 |
| 2024 | 5 | 8 | 13 |
| 2025 | 5 | 5 | 10 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
The gut microbiome and allograft outcomes: implications for heart transplantation. J Clin Invest. 2026 Aug 17; 136(16).
-
The management of rheumatic immune related adverse events. Best Pract Res Clin Rheumatol. 2026 Mar; 40(1):102147.
-
Molecular endotypes predict differential response to immunosuppressant therapy in non-idiopathic pulmonary fibrosis interstitial lung disease. Am J Respir Crit Care Med. 2026 Apr 01; 212(4):768-777.
-
Large language models accurately identify immunosuppression in intensive care unit patients. J Am Med Inform Assoc. 2025 Dec 01; 32(12):1888-1898.
-
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies. Inflamm Bowel Dis. 2025 Oct 01; 31(10):2714-2724.
-
Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study. Lancet Rheumatol. 2026 Apr; 8(4):e253-e264.
-
AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and management of graft-related complications. Liver Transpl. 2026 Mar 01; 32(3):444-490.
-
RAB19, SERPINB9P1, and Pancreatitis in Patients Taking Azathioprine in Routine Clinical Practice: Genome and Transcriptome-Wide Association Studies. Clin Pharmacol Ther. 2025 10; 118(4):946-953.
-
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease. Expert Rev Gastroenterol Hepatol. 2025 Jul; 19(7):725-743.
-
Stem Cell-Derived, Fully Differentiated Islets for Type 1 Diabetes. N Engl J Med. 2025 Sep 04; 393(9):858-868.